⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

Semax

Published Research

PubMed-indexed studies for Semax

Research

Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma.

Bulletin of experimental biology and medicine 2002
View on PubMed →
Research

[Nootropic and analgesic effects of Semax following different routes of administration].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 2010
View on PubMed →
Research

The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.

BMC genomics 2014
View on PubMed →
Research

Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Neurochemical research 2005
View on PubMed →
Research

Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models.

ACS chemical neuroscience 2022
View on PubMed →
Research

[The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain].

Molekuliarnaia biologiia 2021
View on PubMed →

Research-Grade Semax

YPB.229
SEMAX (10mg)
$50.00
View Product →

⚠️ For laboratory research only. Not for human use.